In 1997, Marshall introduced the term ‘pharmacogenomics’ with emergence of the Human Genome Project and advancement of the genome sciences
Pharmacogenomics is the study of how genomics or genetic variation that influence individual response to particular drugs. Individuals with same disease will respond differently to same medications.
Gene Therapy act at the genetic level to produce therapeutic effects that are more effective and long-lasting than traditional medicines. Gene therapy involves the introduction of genetic material into a patient’s cells to address a medical condition or to improve their overall health condition. Using viruses as genetic vectors to deliver the desired gene to the target cells is one method of how gene therapy functions. These vectors are classified as RNA-based or DNA-based viral vectors depending on the type of genome they contain.